Caspase inhibitor decreases apoptosis in pyrogallol-treated lung cancer Calu-6 cells via the prevention of GSH depletion

International Journal of Oncology

Volumn 33, Issue 5, 2008, Pages 1099-1105

  Han, Yong Hwan ^a   Kim, Suhn Hee ^a   Kim, Sung Zoo ^a   Park, Woo Hyun ^a  

^a Chonbuk National University   (South Korea)

Author keywords

Apoptosis; Calu 6; Caspase; Pyrogallol; Reactive oxygen species

Indexed keywords

BENZYLOXYCARBONYLASPARTYLGLUTAMYLVALYLASPARTYL FLUOROMETHYL KETONE; BENZYLOXYCARBONYLISOLEUCYLGLUTAMYLTHREONYLASPARTYL FLUOROMETHYL KETONE; BENZYLOXYCARBONYLLEUCYLGLUTAMYLHISTIDYLASPARTYL FLUOROMETHYL KETONE; CASPASE INHIBITOR; ENZYME INHIBITOR; GLUTATHIONE; PAN CASPASE INHIBITOR; PYROGALLOL; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; CASPASE; CYSTEINE PROTEINASE INHIBITOR;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CONTROLLED STUDY; HUMAN; HUMAN CELL; LUNG CANCER; MITOCHONDRIAL MEMBRANE POTENTIAL; MOLECULAR MECHANICS; PRIORITY JOURNAL; ADENOCARCINOMA; CELL PROLIFERATION; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; LUNG TUMOR; METABOLISM; PATHOLOGY; TIME; TUMOR CELL LINE;

ADENOCARCINOMA; APOPTOSIS; CASPASES; CELL LINE, TUMOR; CELL PROLIFERATION; CYSTEINE PROTEINASE INHIBITORS; GLUTATHIONE; HUMANS; LUNG NEOPLASMS; MEMBRANE POTENTIAL, MITOCHONDRIAL; PYROGALLOL; REACTIVE OXYGEN SPECIES; TIME FACTORS;

EID: 58149192697     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo_00000099     Document Type: Article

References (35)

1. Shi Y: Mechanisms of caspase activation and inhibition during apoptosis. Mol Cell 9: 459-470, 2002.
2. Ashkenazi A and Dixit VM: Death receptors: signaling and modulation. Science 281: 1305-1308, 1998.
3. Budihardjo I, Oliver H, Lutter M, Luo X and Wang X: Biochemical pathways of caspase activation during apoptosis. Annu Rev Cell Dev Biol 15: 269-290, 1999.
4. Mehmet H: Caspases find a new place to hide. Nature 403: 29-30, 2000.
5. Hengartner MO: The biochemistry of apoptosis. Nature 407: 770-776, 2000.
6. Liu X, Yue P, Zhou Z, Khuri FR and Sun SY: Death receptor regulation and celecoxib-induced apoptosis in human lung cancer cells. J Natl Cancer Inst 96: 1769-1780, 2004.
7. Saeki K, Hayakawa S, Isemura M and Miyase T: Importance of a pyrogallol-type structure in catechin compounds for apoptosis-inducing activity. Phytochemistry 53: 391-394, 2000.
8. Yamada J, Yoshimura S, Yamakawa H, et al: Cell permeable ROS scavengers, Tiron and Tempol, rescue PC12 cell death caused by pyrogallol or hypoxia/reoxygenation. Neurosci Res 45: 1-8, 2003.
9. Gonzalez C, Sanz-Alfayate G, Agapito MT, Gomez-Nino A, Rocher A and Obeso A: Significance of ROS in oxygen sensing in cell systems with sensitivity to physiological hypoxia. Respir Physiol Neurobiol 132: 17-41, 2002.
10. Baran CP, Zeigler MM, Tridandapani S and Marsh CB: The role of ROS and RNS in regulating life and death of blood monocytes. Curr Pharm Des 10: 855-866, 2004.
11. Bubici C, Papa S, Pham CG, Zazzeroni F and Franzoso G: The NF-kappaB-mediated control of ROS and JNK signaling. Histol Histopathol 21: 69-80, 2006.
12. Zorov DB, Juhaszova M and Sollott SJ: Mitochondrial ROS-induced ROS release: An update and review. Biochim Biophys Acta 1757: 509-517, 2006.
13. Zelko IN, Mariani TJ and Folz RJ: Superoxide dismutase multigene family: a comparison of the CuZn-SOD (SOD1), Mn-SOD (SOD2), and EC-SOD (SOD3) gene structures, evolution, and expression. Free Radic Biol Med 33: 337-349, 2002.
14. Wilcox CS: Reactive oxygen species: roles in blood pressure and kidney function. Curr Hypertens Rep 4: 160-166, 2002.
15. Chen TJ, Jeng JY, Lin CW, Wu CY and Chen YC: Quercetin inhibition of ROS-dependent and -independent apoptosis in rat glioma C6 cells. Toxicology 223: 113-126, 2006.
16. Dasmahapatra G, Rahmani M, Dent P and Grant S: The tyrphostin adaphostin interacts synergistically with proteasome inhibitors to induce apoptosis in human leukemia cells through a reactive oxygen species (ROS)-dependent mechanism. Blood 107: 232-240, 2006.
17. Wallach-Dayan SB, Izbicki G, Cohen PY, Gerstl-Golan R, Fine A and Breuer R: Bleomycin initiates apoptosis of lung epithelial cells by ROS but not by Fas/FasL pathway. Am J Physiol Lung Cell Mol Physiol 290: L790-L796, 2006.
18. Simon HU, Haj-Yehia A and Levi-Schaffer F: Role of reactive oxygen species (ROS) in apoptosis induction. Apoptosis 5: 415-418, 2000.
19. Moreno-Manzano V, Ishikawa Y, Lucio-Cazana J and Kitamura M: Selective involvement of superoxide anion, but not downstream compounds hydrogen peroxide and peroxynitrite, in tumor necrosis factor-alpha-induced apoptosis of rat mesangial cells. J Biol Chem 275: 12684-12691, 2000.
20. Sawada M, Nakashima S, Kiyono T, et al: p53 regulates ceramide formation by neutral sphingomyelinase through reactive oxygen species in human glioma cells. Oncogene 20: 1368-1378, 2001.
21. Park WH, Han YW, Kim SH and Kim SZ: A superoxide anion generator, pyrogallol induces apoptosis in As4.1 cells through the depletion of intracellular GSH content. Mutat Res 619: 81-92, 2007.
22. Petty RD, Nicolson MC, Kerr KM, Collie-Duguid E and Murray GI: Gene expression profiling in non-small cell lung cancer: from molecular mechanisms to clinical application. Clin Cancer Res 10: 3237-3248, 2004.
23. Park WH, Scol JG, Kim ES, et al: Arsenic trioxide-mediated growth inhibition in MC/CAR myeloma cells via cell cycle arrest in association with induction of cyclin-dependent kinase inhibitor, p21, and apoptosis. Cancer Res 60: 3065-3071, 2000.
24. Setsukinai K, Urano Y, Kakinuma K, Majima HJ and Nagano T: Development of novel fluorescence probes that can reliably detect reactive oxygen species and distinguish specific species. J Biol Chem 278: 3170-3175, 2003.
25. Macho A, Hirsch T, Marzo I, et al: Glutathione depletion is an eariv and calcium elevation is a late event of thymocyte apoptosis. J Immunol 158: 4612-4619, 1997.
26. Hedley DW and Chow S: Evaluation of methods for measuring cellular glutathione content using flow cytometry. Cytometry 15: 349-358, 1994.
27. Yang J, Liu X, Bhalla K, et al: Prevention of apoptosis by Bcl-2: release of cytochrome c from mitqchondria blocked. Science 275: 1129-1132, 1997.
28. Poot M, Teubert H, Rabinovitch PS and Kavanagh TJ: De novo synthesis of glutathione is required for both entry into and progression through the cell cycle. J Cell Physiol 163: 555-560. 1995.
29. Schnelldorfer T, Gansauge S, Gansauge F, Schlosser S, Beger HG and Nussler AK: Glutathione depletion causes cell growth inhibition and enhanced apoptosis in pancreatic cancer cells. Cancer 89: 1440-1447, 2000.
30. Park WH, Han YH, Kim SH and Kim SZ: Pyrogallol, ROS generator inhibits As4.1 juxtaglomerular cells via cell cycle arrest of G2 phase and apoptosis. Toxicology 235: 130-139, 2007.
31. Kim SW, Han YW, Lee ST, et al: A superoxide anion generator, pyrogaflol, inhibits the growth of HeLa cells via cell cycle arrest and apoptosis. Mol Carcinog 47: 114- 125, 2007.
32. Poulese SM, Harris ED and Patil BS: Citrus limonoids induce apoptosis in human neuroblastoma cells and have radical scavenging activity. J Nutr 135: 870-877, 2005.
33. Han YH, Kim SZ, Kim SH and Park WH: Apoptosis in pyrogallol-treated Calu-6 cells is correlated with the changes of intracellular GSH levels rather than ROS levels. Lung Cancer 59: 301-314, 2008.
34. Estrela JM, Ortega A and Obrador E: Glutathione in cancer biology and therapy. Crit Rev Clin Lab Sci 43: 143-181, 2006.
35. Higuchi Y: Glutathione depletion-induced chromosomal DNA fragmentation associated with apoptosis and necrosis. J Cell Mol Med 8: 455-464, 2004.